JPS514121A - - Google Patents

Info

Publication number
JPS514121A
JPS514121A JP50051612A JP5161275A JPS514121A JP S514121 A JPS514121 A JP S514121A JP 50051612 A JP50051612 A JP 50051612A JP 5161275 A JP5161275 A JP 5161275A JP S514121 A JPS514121 A JP S514121A
Authority
JP
Japan
Prior art keywords
hydrogen
stands
aralkyl
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50051612A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6012347B2 (ja
Inventor
Fuoiaa Raasuroo
Furuka Aarupaado
Shebeshuteieen Fuerentsu
Herucheru Yooran
Bendeifui Erujeebeto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU74FE00000928A external-priority patent/HU171576B/hu
Priority claimed from HU74CI1558A external-priority patent/HU174114B/hu
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of JPS514121A publication Critical patent/JPS514121A/ja
Publication of JPS6012347B2 publication Critical patent/JPS6012347B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP50051612A 1974-04-29 1975-04-30 新規アミノ酸誘導体の製法 Expired JPS6012347B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU928 1974-04-29
HU74FE00000928A HU171576B (hu) 1974-04-29 1974-04-29 Sposob otdelenija gamma-l-glutamil-taurina
HU1558 1975-03-26
HU74CI1558A HU174114B (hu) 1975-03-26 1975-03-26 Sposob poluchenija novykh proizvodnykh aminokislot

Publications (2)

Publication Number Publication Date
JPS514121A true JPS514121A (zh) 1976-01-14
JPS6012347B2 JPS6012347B2 (ja) 1985-04-01

Family

ID=26318406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50051612A Expired JPS6012347B2 (ja) 1974-04-29 1975-04-30 新規アミノ酸誘導体の製法

Country Status (23)

Country Link
JP (1) JPS6012347B2 (zh)
AR (3) AR217236A1 (zh)
AT (6) AT361902B (zh)
AU (1) AU499173B2 (zh)
BE (1) BE828546A (zh)
BG (4) BG26517A4 (zh)
CA (1) CA1051802A (zh)
CH (4) CH617183A5 (zh)
CS (4) CS209855B2 (zh)
DD (2) DD125070A5 (zh)
DE (2) DE2518160A1 (zh)
DK (10) DK155433C (zh)
EG (1) EG11847A (zh)
ES (4) ES436986A1 (zh)
FI (1) FI65990C (zh)
FR (1) FR2279388A1 (zh)
GB (1) GB1504541A (zh)
IL (1) IL47149A (zh)
NL (1) NL183186C (zh)
NO (2) NO146430C (zh)
PL (2) PL111746B1 (zh)
SE (2) SE430164B (zh)
SU (1) SU747419A3 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204754A (ja) * 1981-03-27 1985-10-16 キノイン・ジヨ−ジセル・エ−シユ・ヴエジエ−セテイ・テルメ−ケク・ジヤ−ラ・エルテ− ガンマ−グルタミルタウリンの製法
JP2010514674A (ja) * 2006-10-12 2010-05-06 ベラス ヘルス (インターナショナル) リミテッド 3−アミノ−1−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178199B (en) * 1976-05-06 1982-03-28 Chinoin Gyogyszer Es Vegyeszet New process for producing amides of omega-amino-carboxylic acids
HU180443B (en) * 1979-04-02 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a pharmaceutical preparation with synergetic action against radiation
CH665645A5 (fr) * 1981-07-09 1988-05-31 Michel Flork Derives de dipeptides et leur procede de preparation.
HU208072B (en) * 1990-02-28 1993-08-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for preventing and curing autoimmune diseases and skin affections caused by heat and light radiacion
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
JPH11180846A (ja) * 1997-12-15 1999-07-06 Sogo Pharmaceut Co Ltd 化粧料
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US9662304B1 (en) * 2013-06-13 2017-05-30 Thermolife International, Llc Substituted glutaurine compounds and substituted glutaurine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169462B (zh) * 1971-08-04 1976-11-28

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204754A (ja) * 1981-03-27 1985-10-16 キノイン・ジヨ−ジセル・エ−シユ・ヴエジエ−セテイ・テルメ−ケク・ジヤ−ラ・エルテ− ガンマ−グルタミルタウリンの製法
JP2010514674A (ja) * 2006-10-12 2010-05-06 ベラス ヘルス (インターナショナル) リミテッド 3−アミノ−1−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
US8748656B2 (en) 2006-10-12 2014-06-10 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
JP2015007047A (ja) * 2006-10-12 2015-01-15 ビーエイチアイ リミテッド パートナーシップ 3−アミノ−1−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
US10238611B2 (en) 2006-10-12 2019-03-26 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10857109B2 (en) 2006-10-12 2020-12-08 Bellus Health, Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US11020360B2 (en) 2006-10-12 2021-06-01 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Also Published As

Publication number Publication date
ATA314075A (de) 1980-09-15
AR218222A1 (es) 1980-05-30
BG26517A4 (bg) 1979-04-12
DK159654C (da) 1991-04-08
CH621333A5 (zh) 1981-01-30
DK158676C (da) 1991-01-14
BG26368A3 (bg) 1979-03-15
DK155732C (da) 1989-10-02
PL111746B1 (en) 1980-09-30
DK155433C (da) 1989-10-16
AU499173B2 (en) 1979-04-05
NO146430C (no) 1982-09-29
AU8056475A (en) 1976-11-04
NO810816L (no) 1975-10-30
CH617183A5 (zh) 1980-05-14
DK245783D0 (da) 1983-05-31
ATA323079A (de) 1983-09-15
ATA323179A (de) 1982-09-15
DK155520B (da) 1989-04-17
DK182875A (da) 1975-10-30
DK442877A (da) 1977-10-06
IL47149A (en) 1979-05-31
DK155732B (da) 1989-05-08
AR218221A1 (es) 1980-05-30
AT370724B (de) 1983-04-25
CS209857B2 (en) 1981-12-31
DK442477A (da) 1977-10-06
FI65990C (fi) 1984-08-10
AT351007B (de) 1979-07-10
BG26370A4 (bg) 1979-03-15
DD125070A5 (zh) 1977-03-30
AT359085B (de) 1980-10-27
IL47149A0 (en) 1975-06-25
BG26369A4 (bg) 1979-03-15
DK158676B (da) 1990-07-02
CS209856B2 (en) 1981-12-31
JPS6012347B2 (ja) 1985-04-01
FI65990B (fi) 1984-04-30
NL183186C (nl) 1988-08-16
DK443077A (da) 1977-10-06
DE2559989C3 (de) 1981-11-19
SE441356B (sv) 1985-09-30
DK442577A (da) 1977-10-06
ATA624977A (de) 1978-12-15
NO751504L (zh) 1975-10-30
AT359084B (de) 1980-10-27
EG11847A (en) 1979-06-30
SE430164B (sv) 1983-10-24
ES453306A1 (es) 1977-11-16
CS209858B2 (en) 1981-12-31
DK159654B (da) 1990-11-12
SU747419A3 (ru) 1980-07-23
DK159267B (da) 1990-09-24
CS209855B2 (en) 1981-12-31
ATA624877A (de) 1980-03-15
ES436986A1 (es) 1977-06-16
DK159267C (da) 1991-02-18
CH624098A5 (zh) 1981-07-15
ES453304A1 (es) 1977-11-16
DD122377A5 (zh) 1976-10-05
DK155520C (da) 1989-10-16
AR217236A1 (es) 1980-03-14
CH621334A5 (zh) 1981-01-30
DE2559989B1 (de) 1981-02-05
DK155672B (da) 1989-05-01
PL111745B1 (en) 1980-09-30
NO149036B (no) 1983-10-24
SE7504828L (sv) 1975-10-30
DK442377A (da) 1977-10-06
AT374484B (de) 1984-04-25
DK442677A (da) 1977-10-06
FR2279388A1 (fr) 1976-02-20
DK442777A (da) 1977-10-06
FI751256A (zh) 1975-10-30
NL7505075A (nl) 1975-10-31
ES453305A1 (es) 1977-11-16
CA1051802A (en) 1979-04-03
DK245783A (da) 1983-05-31
DK155433B (da) 1989-04-10
FR2279388B1 (zh) 1978-07-28
NO149036C (no) 1984-02-01
DE2518160C2 (zh) 1993-05-06
DE2518160A1 (de) 1975-11-20
DK155672C (da) 1989-10-09
DK442977A (da) 1977-10-06
AT361902B (de) 1981-04-10
ATA624777A (de) 1980-03-15
SE7812884L (sv) 1978-12-14
BE828546A (fr) 1975-08-18
NO146430B (no) 1982-06-21
GB1504541A (en) 1978-03-22

Similar Documents

Publication Publication Date Title
IE39898L (en) Xanthine derivatives
GB1443960A (en) Mild shampoo compositions card system of charge counter
IE820753L (en) Acyl dipeptides
JPS514121A (zh)
KR900003129A (ko) 환형 테트라하이드로피리딘 아세트산 유도체, 이를 제조하는 방법 및 심장보호를 위한 이들 화합물의 용도
IL67381A (en) N-substituted-4-aminomethyl-imidazole derivatives,their preparation and pharmaceutical compositions containing them
ES8303355A1 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
ES479820A1 (es) Procedimiento para la preparacion de isoquinoleinas.
IE38096L (en) Pharmaceutically active phenylpropionic acid preparations
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
SE7906011L (sv) Nya imidazokinoxaliner och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
GB1480836A (en) Physiologically active xanthine derivatives and compositions containing them
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
GB1084150A (zh)
ES8105715A1 (es) Procedimiento de preparar derivados isoquinolinicos
GB1478374A (en) Piperidyl-methylenedioxybenzene derivatives
IE39853B1 (en) New n'-(aminoacylaminophenyl)-acetamidines and salts thereof their production and their medicinal use
ES8203093A1 (es) Un procedimiento para preparar nuevos esteres solubles en agua de esteroide-oxazoles
GB1369580A (en) Tricyclic diphenylamine derivatives
ES464773A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos.
GB1457911A (en) Guanyl-hydrazones
GB1287926A (zh)
GB1457950A (en) Antibacterial compositions
GB1193438A (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them
GB1323170A (en) N,n-diacylhydrazine derivatives and preparation